A Parkinson's patient in the UK reports feeling "cured" after receiving an adaptive deep brain stimulation (DBS) device. Unlike traditional DBS which delivers constant electrical pulses, this new device monitors brain activity and adjusts stimulation accordingly in real time. Tony Howells, diagnosed 15 years ago, experienced significant improvement in his tremors and mobility after the device was implanted, allowing him to return to activities like gardening and playing golf. While researchers caution against using the word "cure," the adaptive DBS technology shows promise for personalized and more effective treatment of Parkinson's disease.
The Therac-25 simulator recreates the software and hardware interface of the infamous radiation therapy machine, allowing users to experience the sequence of events that led to fatal overdoses. It emulates the PDP-11's operation, including data entry, mode switching, and the machine's response, demonstrating how specific combinations of user input and software flaws could bypass safety checks and activate the high-power electron beam without the necessary x-ray attenuating target. By interacting with the simulator, users can gain a concrete understanding of the race conditions, inadequate software testing, and poor error handling that contributed to the tragic accidents.
HN users discuss the Therac-25 simulator and the broader implications of software in safety-critical systems. Several express how chilling and impactful the simulator is, driving home the real-world consequences of software bugs. Some commenters delve into the technical details of the race condition and flawed design choices that led to the accidents. Others lament the lack of proper software engineering practices at the time and the continuing relevance of these lessons today. The simulator itself is praised as a valuable educational tool for demonstrating the importance of rigorous software development and testing, particularly in life-or-death scenarios. A few users share their own experiences with similar systems and emphasize the need for robust error handling and fail-safes.
Summary of Comments ( 15 )
https://news.ycombinator.com/item?id=42857293
HN commenters discuss the exciting potential of adaptive DBS for Parkinson's, but also express caution. Some highlight the small sample size and early stage of the research, emphasizing the need for larger, longer-term studies. Others question the definition of "cured," pointing out that the device manages symptoms rather than addressing the underlying disease. Several commenters delve into the technical aspects of adaptive DBS, comparing it to previous open-loop systems and speculating on future improvements in battery life and personalization. A few share personal anecdotes about family members with Parkinson's, expressing hope for this technology. Finally, some raise concerns about the cost and accessibility of such advanced treatments.
The Hacker News post titled "Parkinson's patient 'feels cured' with new adaptive deep brain stimulation device" sparked a discussion with several interesting comments. Many commenters focused on the limitations of the reporting and the cautious optimism appropriate for such early-stage results.
Several users highlighted the use of the word "cured," pointing out that Parkinson's is a degenerative disease and that this treatment likely manages symptoms rather than addressing the underlying cause. One commenter aptly described it as "symptom suppression" rather than a cure. This theme of managing expectations was echoed by others who stressed the importance of long-term studies to validate the efficacy and durability of the treatment. The small sample size of the initial study was also mentioned as a reason for cautious optimism.
Some commenters brought a more technical perspective, discussing the advancements in deep brain stimulation (DBS) technology. They explained how adaptive DBS differs from traditional DBS, highlighting the closed-loop system's ability to adjust stimulation parameters based on real-time feedback from the brain. This personalized approach, they suggested, could be key to the improved outcomes observed in the study.
The potential cost and accessibility of this new technology were also raised. Commenters acknowledged that while promising, the technology is likely to be expensive, potentially limiting access for many patients.
A few commenters shared personal anecdotes about their experiences with Parkinson's, either as patients or caregivers. These comments added a human element to the discussion, underscoring the impact of the disease and the hope that new treatments like adaptive DBS offer.
Finally, some comments linked to related research and articles, providing further context and information for those interested in delving deeper into the topic of deep brain stimulation and Parkinson's disease. Overall, the comments reflected a mix of excitement tempered by realism, recognizing the potential of this new technology while acknowledging the need for further research and wider accessibility.